Loading insider details...
Beta
Latest Form 4 (Jul 1, 2026): Sale of 23,447 CADL shares, $235.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | Candel Therapeutics, Inc. (CADL) | Sale | 23,447 | $235.8K |
| Jan 28, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 232,000 | n/a |
| Jun 26, 2025 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 4,282 | $20.0K |
| Mar 20, 2025 | Candel Therapeutics, Inc. (CADL) | Exercise/Conversion | 18,000 | $27.9K |
| Feb 14, 2025 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 115,000 | n/a |
| Jan 17, 2025 | Candel Therapeutics, Inc. (CADL) | Sale | 13,534 | $97.8K |
| Jan 10, 2025 | Candel Therapeutics, Inc. (CADL) | Sale | 13,673 | $112.4K |
| Dec 3, 2024 | Candel Therapeutics, Inc. (CADL) | Sale | 22,081 | $100.6K |
| Jul 19, 2024 | Candel Therapeutics, Inc. (CADL) | Sale | 14,051 | $90.9K |
| Jul 15, 2024 | Candel Therapeutics, Inc. (CADL) | Sale | 12,645 | $75.5K |